Preliminary experiments show conolidine may well inhibit specific ion channels, lowering neuronal excitability and restricting discomfort indicators. This system is particularly suitable in neuropathic soreness, exactly where abnormal signaling will cause persistent pain. Furthermore, conolidine appears to affect G protein-coupled receptor (GPCR) pathways integral to soreness notion. ... https://juliusq172fpw5.wikipresses.com/user